Pharmaceutical company
Appears in 1 story · Last updated Oct 25, 2026
Developing dersimelagon as a competing oral EPP drug
People with erythropoietic protoporphyria feel stabbing pain in strong light, and no oral drug is approved to help them. Disc Medicine's bitopertin passed a 183-patient Phase 3 trial called APOLLO, the company said on Oct. 19, 2026, reopening a path to the FDA after a rejection in February.
Updated Oct 25
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
